Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Balancing intellectual monopoly privileges and the need for essential medicines

Date

Authors

Martin, Greg

Sorenson, Corinna

Faunce, Thomas

Publisher

BioMed Central

Abstract

This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions.

Keywords

Keywords: essential drug; new drug; commercial phenomena; drug cost; drug industry; drug research; editorial; health care access; health care delivery; health care policy; health service; human; international cooperation; malaria; patent; priority journal; public h

Citation

Globalization and Health 3.4 (2007): 1-5

URI

http://hdl.handle.net/10440/21
http://digitalcollections.anu.edu.au/handle/10440/21

Collections

Open Access Research

Source

Globalization and Health

Type

Journal article

DOI

10.1186/1744-8603-3-4

Downloads

File

Description

Faunce_Balancing.pdf (197.01 KB)